On the other hand, higher baseline ACE2 levels have been reported in children, young people and women that are characterized with better prognosis, mild symptoms and lower case fatality rate (CFR) during COVID-19 [12,13,14,15]. This evidence concerns the gene ACE2 and COVID-19.